INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹1.22 Cr | ₹6.29 Cr | ₹2.41 Cr | ₹1.46 Cr | ₹1.53 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDO US BIOTECH ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹1.22 Cr |
Mar2023 | ₹6.29 Cr |
Mar2022 | ₹2.41 Cr |
Mar2021 | ₹1.46 Cr |
Mar2020 | ₹1.53 Cr |
How is Cash Flow from Financing Activities of INDO US BIOTECH Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹1.22 Cr | -80.68 | |
Mar2023 | ₹6.29 Cr | 160.95 | |
Mar2022 | ₹2.41 Cr | 64.96 | |
Mar2021 | ₹1.46 Cr | -4.38 | |
Mar2020 | ₹1.53 Cr | - |
Compare Cash Flow from Financing Activities of peers of INDO US BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDO US BIOTECH | ₹308.6 Cr | 1.5% | 1.6% | -27% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,934.7 Cr | -5.8% | -6.3% | 14.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,436.8 Cr | -5.7% | -15.3% | 32.9% | Stock Analytics | |
VENKYS (INDIA) | ₹2,264.3 Cr | -1.5% | 0.4% | -16.7% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,435.5 Cr | -2% | -1.8% | -33.7% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹481.8 Cr | 3.5% | 11.2% | NA | Stock Analytics |
INDO US BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | 1.5% |
1.6% |
-27% |
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses